Atlas Trials

Immunomodulatory Effects of IVIg on Pregnancy Rate of Patient With Recurrent Pregnancy Loss

Clinical trial NCT03174951 · COMPLETED

Trial details

NCT number
NCT03174951
Sponsor
Tabriz University of Medical Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Pregnancy Loss
Start date
2016-09-20
Primary completion
2017-03-10
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.